The Helios Alliance

The Helios Alliance is a multi-stakeholder collaborative research organization dedicated to accelerating the development of therapeutics and diagnostics for liver diseases, specifically Metabolic Dysfunction-Associated Steatohepatitis (MASH). The alliance integrates a high-quality clinical trial network with a comprehensive longitudinal database to provide real-world evidence and streamlined trial execution. By connecting academic centers, community practices, and industry partners, Helios aims to optimize patient recruitment and standardize data collection across the MASH landscape. Their platform supports the entire lifecycle of drug development, from early-stage research to post-marketing studies. The organization focuses on addressing the significant unmet need in hepatology by providing high-resolution data and access to diverse patient populations.